Optimizing Diabetes Care Through Clinical Pharmacy Services

1. The patient-centered medical home (PCMH) model has been associated with improved chronic disease management, increased patient and provider satisfaction, cost savings, improved quality of care, and increased preventive care.

a) True
b) False

2. Dialysis rounds with a clinical pharmacist helps streamline communication between the dialysis center medical staff with primary care providers and clinical care coordinators.

a) True
b) False

3. The pharmacy outreach team conducts home visits for patients who have transportation difficulties and those who need close follow-up that can be completed at home.

a) True
b) False

4. Clinical pharmacist implementation into the diabetes care management team leads to:

a) Reduced burden on primary care providers
b) Increase patient access to health care
c) Improvement of Government Performance and Results Act (GRPA) targets
d) Improved patient quality of life and satisfaction
e) All of the above

5. Compared to usual care, pharmacist-managed patients were approximately 20% more likely to achieve target A1c goals.

a) True
b) False

6. Whiteriver Clinical Pharmacists are fully integrated into the following areas of ambulatory care:

a) Internal medicine
b) Dialysis
c) Home visits
d) Urgent Care
e) All of the above

7. Clinical pharmacists collaborate with diabetes educators, dietitians, and physical therapists to optimize multi-disciplinary services and support patients in achieving their goals.

a) True
b) False

8. The Chronic Disease Therapy Management (CDTM) collaborative practice agreement (CPA) allows pharmacists to manage any chronic condition which is treated with medications, including:

a) Endocrinology
b) Pulmonology
c) Rheumatology
d) Gastroenterology
e) All of the above

9. Pharmacist-managed diabetes clinics significantly improved diabetes-related parameters, achieved A1c goals more frequently and enhanced nephropathy screening rates.

a) True
b) False